VTv Therapeutics - 48 Year Dividend History | VTVT

Historical dividend payout and yield for VTv Therapeutics (VTVT) since 1971. The current TTM dividend payout for VTv Therapeutics (VTVT) as of July 17, 2019 is $0.00. The current dividend yield for VTv Therapeutics as of July 17, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.078B $0.012B
vTv Therapeutics Inc. is a biopharmaceutical company which is engaged in the discovery and development of orally administered small molecule drug candidates to fill unmet medical needs. Its drug candidate for the treatment of Alzheimers disease includes azeliragon TTP488, which is in Phase III clinical trials; type II diabetes drug candidates include Glucokinase Activator TTP399 and GLP-1r Agonist TTP273 which completed Phase I clinical trials; products for the prevention of muscle weakness and treatment of inflammatory disorders include HPP593, HPP737 and HPP971 which is in Phase1 clinical trials. The Company's drug discovery platform consists of TTP Translational Technology. vTv Therapeutics Inc. is headquartered in High Point, North Carolina.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $108.245B 12.24
Gilead Sciences (GILD) United States $85.342B 10.36
CSL (CSLLY) Australia $35.409B 0.00
Bio-Techne Corp (TECH) United States $7.964B 54.34